An analysis of the Swedish BioFINDER2 data evidenced an association of higher MBI‐C scores and higher tau PET deposition in the entorhinal cortex/hippocampus and pTau181 in CSF in Aβ + preclinical AD participants,38 as opposed to findings in ADNI,11 possibly due to tau PET measurement methods. This evidence concerns the gene MAPT and Alzheimer disease.